|
Clerk of the House of Representatives Legislative Resource Center 135 Cannon Building Washington, DC 20515 http://lobbyingdisclosure.house.gov |
Secretary of the Senate Office of Public Records 232 Hart Building Washington, DC 20510 http://www.senate.gov/lobby |
LOBBYING REGISTRATION
Lobbying Disclosure Act of 1995 (Section 4)
| 1. Effective Date of Registration | 7/29/2026 |
||||
| 2. House Identification | 31784 |
Senate Identification | 682 |
||
REGISTRANT Organization/Lobbying Firm Self Employed Individual
| 3. Registrant | Organization | AKIN GUMP STRAUSS HAUER & FELD |
||||
| Address | 2001 K St NW |
Address2 |
|
| City | WASHINGTON |
State | DC |
Zip | 20006 |
Country | USA |
4. Principal place of business (if different than line 3)
| City |
|
State |
|
Zip |
|
Country |
|
| 5. Contact name and telephone number | International Number |
| Contact | Ms. Melissa Laurenza |
Telephone | 2028874000 |
ldareporting@akingump.com |
CLIENT A Lobbying Firm is required to file a separate registration for each client. Organizations employing in-house lobbyists should check the box labeled “Self” and proceed to line 10. Self
| 7. Client name | Healthcare Distribution Alliance |
| Address | 1275 Pennsylvania Ave NW, Suite 600 |
| City | Washington |
State | DC |
Zip | 20004 |
Country | USA |
| City |
|
State |
|
Zip |
|
Country |
|
LOBBYISTS
10. Name of each individual who has acted or is expected to act as a lobbyist for the client identified on line 7. If any person listed in this section has served as a “covered executive branch official” or “covered legislative branch official” within twenty years of first acting as a lobbyist for the client, state the executive and/or legislative position(s) in which the person served.
| Name | Covered Official Position (if applicable) | ||
First |
Last |
Suffix |
|
| Virgil | Miller | | Policy Fellow, Rep. Edolphus Towns, Aug06 - Feb07; Prof Staff Mber, Commit on Eng and Com, Feb 07 - Jan 11; Health Policy Advisor, Rep. John D. Dingell, Jan 09 - Jan 11; CoS, Rep. Cedric Richmond, Jan 11 - Mar 19. |
| Molly | Brimmer-Lolli | | Sr Cnsl, H Energy&Commrce Comm, Health Subcomm (2025-26); Cnsl H Energy&Commrce Comm, Health Subcomm (2023-25); Leg Dir, Rep. Hudson (2022-23); Sr Health Policy Advsr Rep. Hudson (2021-22); Leg Asst, Rep. Harris (2019-2021); Intrn, Rep. Harris (2014) |
| Geoff | Verhoff | | Press aide, ofc of Sen Roth, Nov 00-Jan 01; press aide, S Fin Comm, Aug 99-Nov 00. |
| Anna | Abram | | Dpty Comm, Pol, Leg, Intnl Affrs, FDA, Mar19Jan21; Mar17Mar19; Spcl Asst HHS, Jan21Mar17; Dec09Jan21; Hlth Dirctr, Sen Burr, Sen Hlth, L&P Comm, Apr09Dec09; Stff Mbr, Sen VA Comm, Feb09Apr09; AsstDrctr, WH Jan0709; LA, LC, SA, SenSantorum, May03Dec06 |
| Shawn Maree | Bishop | | Chief Health Advisor, US Sen. Finance Comm. (2/16/21-11/15/2024); Senior Advisor, US Sen. Finance Comm. (5/6/19 - 10/1/19); Professional Staff, US Sen. Finance Comm. (2/5/2005-10/1/2010). |
LOBBYING ISSUES
11. General lobbying issue areas (Select all applicable codes).
HCR |
|
|
|
|
|
|
|
|
12. Specific lobbying issues (current and anticipated)
Issues related to distributor-supported service models and related policy.
AFFILIATED ORGANIZATIONS
13. Is there an entity other than the client that contributes more than $5,000 to the lobbying activities of the registrant in a quarterly period and either participates in and/or in whole or in major part supervises or controls the registrant’s lobbying activities?
| No --> Go to line 14. | Yes --> Complete the rest of this section for each entity matching the criteria above, then proceed to line 14. |
| Internet Address: |
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
FOREIGN ENTITIES
14. Is there any foreign entity
a) holds at least 20% equitable ownership in the client or any organization identified on line 13; or
b) directly or indirectly, in whole or in major part, plans, supervises, controls, directs, finances or subsidizes activities of the client or any organization identified on line 13; or
c) is an affiliate of the client or any organization identified on line 13 and has a direct interest in the outcome of the lobbying activity?
| No --> Sign and date the registration. | Yes --> Complete the rest of this section for each entity matching the criteria above, then sign the registration. |
| Address | Ownership | |||||
| Name | Street | Principal place of business | Amount of contribution | |||
|
(city and state or country) | for lobbying activities | ||||
|
|
|||||||||||
|
|
|
|
|
% | |||||||
|
|
|||||||||||
|
|
|
|
|
% |
CONVICTIONS DISCLOSURE
15. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery,
extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
| Signature | Digitally Signed By: Brian Pomper |
Date | 10/1/2026 1:14:40 PM |
10. Supplemental. List any additional lobbyists for this client not listed on page 1, number 10.
| Name | Covered Official Position (if applicable) | Have you been convicted of a crime? | ||
First |
Last |
Suffix |
||
| Ryan | Ellis | | | |
| Jocelyn | Wiles | | Staffer, Rep. Kathy Castor (Jan. 07 - Feb. 11); Intern/Fellow, Rep. Barbara Lee (2006); Intern, Rep. Danny Davis (2004). | |
| Mara | LeFevre | | Leg. Asst., Sen. Hoeven (2025-2026); Leg. Aide, Sen. Hoeven (2025); Leg. Cor., Sen. Hoeven (2023-2024); Staff Asst., Sen. Hoeven (2022-2023); Intern, Sen. KCramer (2020). | |
| | | | | |
| | | | | |
| | | | | |
|
|
|
|
|
|
|
|
|
| Name | Address | Principal Place of Business | ||||||||
| Street | ||||||||||
|
||||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
|||||||||
|
|
|
||||||||
|
|
| Name | Address |
Principal place of business (city and state or country) |
Amount of contribution for lobbying activities | Ownership | ||||||||||||||
| ||||||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||
|
|
|
|
% |
||||||||||||||